Zimmer Biomet (NYSE:ZBH) said today that it expects to close its $1 billion acquisition of LDR Holding (NSDQ:LDRH) later today, after its $37-per-share tender offer reaped about 88.9% of LDR’s outstanding shares. The deal, which last month cleared the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, isn’t expected to affect Zimmer Biomet’s sales outlook, with adjusted earnings per share likewise unaffected […]
Zimmer Biomet (NYSE:ZBH) said today that its pending, $1 billion acquisition of LDR Holding (NSDQ:LDRH) cleared the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The $37-per-share offer for LDR, which makes the Mobi-C cervical disc replacement and Mivo lumbar and cervical fusion devices, is slated to expire at midnight July 13; today Zimmer said it expects to close the […]
Zimmer Biomet (NYSE:ZBH) said today it is buying spinal medical device company LDR Holding for approximately $1 billion. Boards from both companies approved the acquisition agreement, the company said, with Zimmer Biomet slated to acquire all outstanding shares of LDR at $37 per share in cash. The company expects the deal to close in the 3rd […]
LDR Holding Corp. announced that it’s making a bid for its initial public offering, aiming to sell its stock on the NASDAQ global market under the stock ticker ‘LDRH’, according to a company statement.
The company Texas-based spinal device company did not disclose the number of shares or detailed pricing for the IPO, but filed for an offering of up to $69 million, SEC documents show.
Austin, Tex.-based LDR landed its 1st FDA approval for its Mobi-C device, a cervical disc replacement for patients with degenerative disc disease.
The privately held company, which was founded in France but is headquartered in Texas, is marketing the product as better alternative to a last-resort procedure called anterior cervical discectomy fusion, which fuses the vertebra to ease painful symptoms of a herniated disk.